Advanced Filters
noise

Spandau, Germany Clinical Trials

A listing of Spandau, Germany clinical trials actively recruiting patients volunteers.

Found 403 clinical trials

Avacostar - (PASS)

The Avacostar PASS is a non-interventional, multi-national, prospective cohort study that will collect data from 2 cohorts of patients: those treated with avacopan for active severe AAV, and a second cohort treated with a cyclophosphamide or rituximab-based induction regimen without avacopan for active severe AAV. The overall study duration is …

18 years of age All Phase N/A
S Stefan J Schaller, MD

Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness

In this mono-center pilot trial, surgical patients who are at high risk to be admitted to intensive care will be screened and asked for participation. We are going to take blood and muscle samples at respecified time points to do metabolic, histological and molecular testing. Aim of the study is …

18 years of age All Phase N/A
H Henryk Dreger, Prof. Dr. med.

Berlin Registry of Right Heart Interventions

The present study evaluates patients after interventional therapy of valvular diseases of the right heart. Follow-up examinations include medical history taking, laboratory measurements and an echo. The aim is to assess the different interventional therapies and their impact on patient's outcome.

18 - 120 years of age All Phase N/A
A Andreas Heinz, Prof.

Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer

Individuals with substance use disorders (SUD) have to cope with drug-related cues and contexts, which can affect instrumental drug seeking as shown with Pavlovian to instrumental transfer (PIT) paradigms in animals and humans. The investigators aimed to investigate the impact of acute and chronic stress on Pavlovian-to-instrumental transfer (PIT), how …

16 - 65 years of age All Phase N/A
S Sabine Dölle-Bierke, PhD

EPAP, Interviewstudy

The goal of this observational study is to learn about repetitive anaphylactic reactions in food allergic patients and to compare the frequency of repetitive reactions between different elicitors in food allergic patients. The main question it aims to answer are: • Is there an elicitor specific difference in the occurrence …

years of age All Phase N/A
J Janine Pöss, Dr.

German Cardiac Arrest Registry

In Germany, 70.000 to 100.000 patients suffer from out-of-hospital cardiac arrest (OHCA) every year. More than half of these are due to cardiac causes. Despite the medical progress over the last decades, rates of survival with good neurological outcome remain low. For many below-mentioned issues, no adequate evidence from randomized …

18 years of age All Phase N/A
G Gesa Schlak, MD

The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

In a monocentric, later multicentric prospective approach the FOrMe registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry) aims to generate a longitudinal cohort of 150 pediatric cases of idiopathic nephrotic syndrome and 350 adult cases of biopsy-proven Minimal Change Disease (MCD) or Focal and Segmental Glomerular Sclerosis …

years of age All Phase N/A
S Stefan Habringer, MD

Secondary Central Nervous System Lymphoma Registry - Charité

The objective of the observation is to collect and document data on treatment strategies for secondary central nervous system lymphoma (SCNSL) in routine clinical practice, whether obtained in the context of clinical trials or outside of trials. In particular, the following questions will be specified: What therapeutic approaches are being …

years of age All Phase N/A
M Margitta Worm, Prof.

Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation

Currently, patients with moderate to severe atopic dermatitis are treated with dupilumab if unresponsive to topical treatment. However, not all patients who suffer from atopic dermatitis respond similarly to this treatment. Pattern recognition of immune cells (PRI) is an efficient method to screen patients to allow a more personalized therapy. …

18 - 75 years of age All Phase N/A
V Vincenzo Caccavo, Dr.

Optimizer System With ODOCOR II CCM™ Leads

The objective of the ODOCOR II CCM lead study is to evaluate the safety and useability of the ODOCOR II intra-cardiac lead specifically intended to deliver CCM as an accessory lead to the Optimizer IPG.

18 years of age All Phase N/A

Simplify language using AI